Jens Bedke (J Bedke)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2015-2024
Publications (10 Years): 34

Top Topics

Tyrosine Kinase

Radical Prostatectomy

Renal Cell Carcinoma

Top Venues

World journal of urology

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Expert opinion on biological therapy

Journal of clinical medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Robert J Motzer, Camillo Porta, Masatoshi Eto, Thomas Powles, Viktor Gruenwald, Thomas E Hutson, Boris Alekseev, Sun Young Rha, Jaime R Merchan, Jeffrey C Goh, Aly-Khan A Lalani, Ugo De Giorgi, Bohuslav Melichar, Sung-Hoo Hong, Howard Gurney, Maria Jose Mendez, Evgeny Kopyltsov, Sergey A Tjulandin, Teresa Alonso Gordoa, Vadim Kozlov, Anna Alyasova, Eric Winquist, Pablo Maroto, Miso Kim, Avivit Peer, Giuseppe Procopio, Toshio Takagi, Shirley Wong, Jens Bedke, Manuela Schmidinger, Karla Rodriguez-Lopez, Joseph Burgents, Cixin He, Chinyere E Okpara, Jodi-Ann Mckenzie, Toni K Choueiri, null null
Lenvatinib Plus Pembrolizumab Versus Sunitinib in First-Line Treatment of Advanced Renal Cell Carcinoma: Final Prespecified Overall Survival Analysis of CLEAR, a Phase III Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (11) (2024)
Robert J Motzer, Camillo Porta, Masatoshi Eto, Thomas Powles, Viktor Gruenwald, Thomas E Hutson, Boris Alekseev, Sun Young Rha, Jaime R Merchan, Jeffrey C Goh, Aly-Khan A Lalani, Ugo De Giorgi, Bohuslav Melichar, Sung-Hoo Hong, Howard Gurney, Maria Jose Mendez, Evgeny Kopyltsov, Sergey A Tjulandin, Teresa Alonso Gordoa, Vadim Kozlov, Anna Alyasova, Eric Winquist, Pablo Maroto, Miso Kim, Avivit Peer, Giuseppe Procopio, Toshio Takagi, Shirley Wong, Jens Bedke, Manuela Schmidinger, Karla Rodriguez-Lopez, Joseph Burgents, Cixin He, Chinyere E Okpara, Jodi-Ann Mckenzie, Toni K Choueiri, null null
Lenvatinib Plus Pembrolizumab Versus Sunitinib in First-Line Treatment of Advanced Renal Cell Carcinoma: Final Prespecified Overall Survival Analysis of CLEAR, a Phase III Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (11) (2024)
Robert J Motzer, Camillo Porta, Masatoshi Eto, Thomas Powles, Viktor Gruenwald, Thomas E Hutson, Boris Alekseev, Sun Young Rha, Jaime R Merchan, Jeffrey C Goh, Aly-Khan A Lalani, Ugo De Giorgi, Bohuslav Melichar, Sung-Hoo Hong, Howard Gurney, Maria Jose Mendez, Evgeny Kopyltsov, Sergey A Tjulandin, Teresa Alonso Gordoa, Vadim Kozlov, Anna Alyasova, Eric Winquist, Pablo Maroto, Miso Kim, Avivit Peer, Giuseppe Procopio, Toshio Takagi, Shirley Wong, Jens Bedke, Manuela Schmidinger, Karla Rodriguez-Lopez, Joseph Burgents, Cixin He, Chinyere E Okpara, Jodi-Ann Mckenzie, Toni K Choueiri, null null
Lenvatinib Plus Pembrolizumab Versus Sunitinib in First-Line Treatment of Advanced Renal Cell Carcinoma: Final Prespecified Overall Survival Analysis of CLEAR, a Phase III Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Robert J Motzer, Camillo Porta, Masatoshi Eto, Thomas Powles, Viktor Gruenwald, Thomas E Hutson, Boris Alekseev, Sun Young Rha, Jaime R Merchan, Jeffrey C Goh, Aly-Khan A Lalani, Ugo De Giorgi, Bohuslav Melichar, Sung-Hoo Hong, Howard Gurney, Maria Jose Mendez, Evgeny Kopyltsov, Sergey A Tjulandin, Teresa Alonso Gordoa, Vadim Kozlov, Anna Alyasova, Eric Winquist, Pablo Maroto, Miso Kim, Avivit Peer, Giuseppe Procopio, Toshio Takagi, Shirley Wong, Jens Bedke, Manuela Schmidinger, Karla Rodriguez-Lopez, Joseph Burgents, Cixin He, Chinyere E Okpara, Jodi-Ann Mckenzie, Toni K Choueiri, null null
Lenvatinib Plus Pembrolizumab Versus Sunitinib in First-Line Treatment of Advanced Renal Cell Carcinoma: Final Prespecified Overall Survival Analysis of CLEAR, a Phase III Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (11) (2024)
Robert J Motzer, Camillo Porta, Masatoshi Eto, Thomas Powles, Viktor Gruenwald, Thomas E Hutson, Boris Alekseev, Sun Young Rha, Jaime R Merchan, Jeffrey C Goh, Aly-Khan A Lalani, Ugo De Giorgi, Bohuslav Melichar, Sung-Hoo Hong, Howard Gurney, Maria Jose Mendez, Evgeny Kopyltsov, Sergey A Tjulandin, Teresa Alonso Gordoa, Vadim Kozlov, Anna Alyasova, Eric Winquist, Pablo Maroto, Miso Kim, Avivit Peer, Giuseppe Procopio, Toshio Takagi, Shirley Wong, Jens Bedke, Manuela Schmidinger, Karla Rodriguez-Lopez, Joseph Burgents, Cixin He, Chinyere E Okpara, Jodi-Ann Mckenzie, Toni K Choueiri, null null
Lenvatinib Plus Pembrolizumab Versus Sunitinib in First-Line Treatment of Advanced Renal Cell Carcinoma: Final Prespecified Overall Survival Analysis of CLEAR, a Phase III Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (11) (2024)
Viktoria Stühler, Bilal Alemi, Steffen Rausch, Arnulf Stenzl, Matthias Schwab, Elke Schaeffeler, Jens Bedke
Analysis of the immunological markers BTLA, TIM-3, and PD-L1 at the invasion front and tumor center in clear cell renal cell carcinoma. World journal of urology 42 (1) (2024)
Robert J Motzer, Camillo Porta, Masatoshi Eto, Thomas Powles, Viktor Gruenwald, Thomas E Hutson, Boris Alekseev, Sun Young Rha, Jaime R Merchan, Jeffrey C Goh, Aly-Khan A Lalani, Ugo De Giorgi, Bohuslav Melichar, Sung-Hoo Hong, Howard Gurney, Maria Jose Mendez, Evgeny Kopyltsov, Sergey A Tjulandin, Teresa Alonso Gordoa, Vadim Kozlov, Anna Alyasova, Eric Winquist, Pablo Maroto, Miso Kim, Avivit Peer, Giuseppe Procopio, Toshio Takagi, Shirley Wong, Jens Bedke, Manuela Schmidinger, Karla Rodriguez-Lopez, Joseph Burgents, Cixin He, Chinyere E Okpara, Jodi-Ann Mckenzie, Toni K Choueiri, null null
Lenvatinib Plus Pembrolizumab Versus Sunitinib in First-Line Treatment of Advanced Renal Cell Carcinoma: Final Prespecified Overall Survival Analysis of CLEAR, a Phase III Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (11) (2024)
Viktoria Stühler, Bilal Alemi, Steffen Rausch, Arnulf Stenzl, Matthias Schwab, Elke Schaeffeler, Jens Bedke
Analysis of the immunological markers BTLA, TIM-3, and PD-L1 at the invasion front and tumor center in clear cell renal cell carcinoma. World journal of urology 42 (1) (2024)
Niklas Harland, Mohammed Alfarra, Eva Erne, Moritz Maas, Bastian Amend, Jens Bedke, Arnulf Stenzl
A Peritoneal Purse-String Suture Prevents Symptomatic Lymphoceles in Retzius-Sparing Robot-Assisted Radical Prostatectomy. Journal of clinical medicine 12 (3) (2023)
Moritz Maas, Aymone Kurcz, Jörg Hennenlotter, Marcus Scharpf, Falko Fend, Simon Walz, Viktoria Stühler, Tilman Todenhöfer, Arnulf Stenzl, Jens Bedke, Steffen Rausch
Differential Expression and Clinical Relevance of C-X-C Motif Chemokine Receptor 4 (CXCR4) in Renal Cell Carcinomas, Benign Renal Tumors, and Metastases. International journal of molecular sciences 24 (6) (2023)
Niklas Harland, Mohammed Alfarra, Eva Erne, Moritz Maas, Bastian Amend, Jens Bedke, Arnulf Stenzl
A Peritoneal Purse-String Suture Prevents Symptomatic Lymphoceles in Retzius-Sparing Robot-Assisted Radical Prostatectomy. Journal of clinical medicine 12 (3) (2023)
Moritz Maas, Aymone Kurcz, Jörg Hennenlotter, Marcus Scharpf, Falko Fend, Simon Walz, Viktoria Stühler, Tilman Todenhöfer, Arnulf Stenzl, Jens Bedke, Steffen Rausch
Differential Expression and Clinical Relevance of C-X-C Motif Chemokine Receptor 4 (CXCR4) in Renal Cell Carcinomas, Benign Renal Tumors, and Metastases. International journal of molecular sciences 24 (6) (2023)
Moritz Maas, Aymone Kurcz, Jörg Hennenlotter, Marcus Scharpf, Falko Fend, Simon Walz, Viktoria Stühler, Tilman Todenhöfer, Arnulf Stenzl, Jens Bedke, Steffen Rausch
Differential Expression and Clinical Relevance of C-X-C Motif Chemokine Receptor 4 (CXCR4) in Renal Cell Carcinomas, Benign Renal Tumors, and Metastases. International journal of molecular sciences 24 (6) (2023)
Niklas Harland, Mohammed Alfarra, Eva Erne, Moritz Maas, Bastian Amend, Jens Bedke, Arnulf Stenzl
A Peritoneal Purse-String Suture Prevents Symptomatic Lymphoceles in Retzius-Sparing Robot-Assisted Radical Prostatectomy. Journal of clinical medicine 12 (3) (2023)
Viktoria Stühler, Lisa Herrmann, Moritz Maas, Simon Walz, Steffen Rausch, Arnulf Stenzl, Jens Bedke
Prognostic impact of complete metastasectomy in metastatic renal cell carcinoma in the era of immuno-oncology-based combination therapies. World journal of urology 40 (5) (2022)
Wolfgang M Thaiss, Simone Moser, Tobias Hepp, Stephan Kruck, Steffen Rausch, Marcus Scharpf, Konstantin Nikolaou, Arnulf Stenzl, Jens Bedke, Sascha Kaufmann
Head-to-head comparison of biparametric versus multiparametric MRI of the prostate before robot-assisted transperineal fusion prostate biopsy. World journal of urology 40 (10) (2022)
Niklas Klümper, Damian J Ralser, Joerg Ellinger, Florian Roghmann, Julia Albrecht, Eduard Below, Abdullah Alajati, Danijel Sikic, Johannes Breyer, Christian Bolenz, Friedemann Zengerling, Philipp Erben, Kristina Schwamborn, Ralph M Wirtz, Thomas Horn, Dora Nagy, Marieta Ioana Toma, Glen Kristiansen, Thomas Büttner, Oliver Hahn, Viktor Gruenwald, Christopher Darr, Eva Erne, Steffen Rausch, Jens Bedke, Katrin Schlack, Mahmoud Abbas, Stefanie Zschäbitz, Constantin Schwab, Alexander Mustea, Patrick Adam, Andreas Manseck, Bernd Wullich, Manuel Ritter, Arndt Hartmann, Juergen E Gschwend, Wilko Weichert, Franziska Erlmeier, Michael Hudecek, Markus Eckstein
Membranous NECTIN-4 expression frequently decreases during metastatic spread of urothelial carcinoma and is associated with enfortumab vedotin resistance. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Tobias Hepp, Laura Kalmbach, Manuel Kolb, Petros Martirosian, Tom Hilbert, Wolfgang M Thaiss, Mike Notohamiprodjo, Jens Bedke, Konstantin Nikolaou, Arnulf Stenzl, Stephan Kruck, Sascha Kaufmann
T2 mapping for the characterization of prostate lesions. World journal of urology 40 (6) (2022)
Carlo Di Bona, Viktoria Stühler, Steffen Rausch, Arnulf Stenzl, Jens Bedke
Pembrolizumab for the treatment of renal cell carcinoma. Expert opinion on biological therapy 21 (9) (2021)
Viktoria Stühler, Steffen Rausch, Katharina Kroll, Marcus Scharpf, Arnulf Stenzl, Jens Bedke
The prognostic value of fat invasion and tumor expansion in the hilar veins in pT3a renal cell carcinoma. World journal of urology 39 (9) (2021)
Carolin Sauter-Meyerhoff, Regina Bohnert, Pascale Mazzola, Viktoria Stühler, Siarhei Kandabarau, Florian A Büttner, Stefan Winter, Lisa Herrmann, Steffen Rausch, Jörg Hennenlotter, Falko Fend, Marcus Scharpf, Arnulf Stenzl, Stephan Ossowski, Jens Bedke, Matthias Schwab, Elke Schaeffeler
Characterization of Genetic Heterogeneity in Recurrent Metastases of Renal Cell Carcinoma. Cancers 13 (24) (2021)
Viktoria Stühler, Steffen Rausch, Jan Moritz Maas, Arnulf Stenzl, Jens Bedke
Combination of immune checkpoint inhibitors and tyrosine kinase inhibitors for the treatment of renal cell carcinoma. Expert opinion on biological therapy 21 (9) (2021)
Valentina Norz, Laura Lawaczeck, Jens Bedke, Steffen Rausch, Arnulf Stenzl
Enzalutamide plus androgen-deprivation therapy in hormone-sensitive prostate cancer: new perspectives from a current Phase III clinical trial. Future oncology (London, England) 16 (21) (2020)
Moritz Maas, Viktoria Stühler, Simon Walz, Arnulf Stenzl, Jens Bedke
Enfortumab vedotin - next game-changer in urothelial cancer. Expert opinion on biological therapy 21 (7) (2020)
Viktoria Stühler, Jan Moritz Maas, Simon Walz, Arnulf Stenzl, Jens Bedke
An evaluation of avelumab for the treatment of genitourinary tumors. Expert opinion on biological therapy 20 (9) (2020)
Philipp Ivanyi, Carsten Grüllich, Nils Kroeger, Thomas Gauler, Manfred Johannsen, Jens Bedke, Viktor Grünwald, null null
Systemic treatment of advanced/metastatic renal cell carcinoma in the context of SARS-CoV-2 pandemic: recommendations from the interdisciplinary working group for renal tumors (IAG-N). Journal of cancer research and clinical oncology 146 (11) (2020)
Moritz Maas, Simon Walz, Viktoria Stühler, Stefan Aufderklamm, Steffen Rausch, Jens Bedke, Arnulf Stenzl, Tilman Todenhöfer
Molecular markers in disease detection and follow-up of patients with non-muscle invasive bladder cancer. Expert review of molecular diagnostics 18 (5) (2019)
Viktoria Stühler, Jan Moritz Maas, Steffen Rausch, Arnulf Stenzl, Jens Bedke
Immune checkpoint inhibition for the treatment of renal cell carcinoma. Expert opinion on biological therapy 20 (1) (2019)
J Marzec, J Becker, F Paulsen, D Wegener, S-C Olthof, C Pfannenberg, J Schwenck, Jens Bedke, A Stenzl, K Nikolaou, C la Fougère, D Zips, Arndt-Christian Müller
68Ga-PSMA-PET/CT-directed IGRT/SBRT for oligometastases of recurrent prostate cancer after initial surgery. Acta oncologica (Stockholm, Sweden) 59 (2) (2019)
Viktoria Stühler, Jan Moritz Maas, Jonas Bochem, Inês Anselmo da Costa, Tilman Todenhöfer, Arnulf Stenzl, Jens Bedke
Molecular predictors of response to PD-1/PD-L1 inhibition in urothelial cancer. World journal of urology 37 (9) (2018)
M Hegemann, N Kroeger, A Stenzl, Jens Bedke
Rare and changeable as a chameleon: paraneoplastic syndromes in renal cell carcinoma. World journal of urology 36 (6) (2018)
Wolfgang M Thaiss, Jens Bedke, Stephan Kruck, Daniel Spira, Arnulf Stenzl, Konstantin Nikolaou, Marius Horger, Sascha Kaufmann
Can contrast-enhanced ultrasound and acoustic radiation force impulse imaging characterize CT-indeterminate renal masses? A prospective evaluation with histological confirmation. World journal of urology 37 (7) (2018)
Tilman Todenhöfer, Jörg Hennenlotter, Gabriel Keller, Tim Neumann, Arnulf Stenzl, Jens Bedke
Effect of radical prostatectomy on levels of cancer related epitopes in circulating macrophages of patients with clinically localized prostate cancer. The Prostate 77 (12) (2017)
S Kaufmann, J Mischinger, B Amend, S Rausch, M Adam, M Scharpf, F Fend, U Kramer, M Notohamiprodjo, K Nikolaou, A Stenzl, Jens Bedke, S Kruck
First report of robot-assisted transperineal fusion versus off-target biopsy in patients undergoing repeat prostate biopsy. World journal of urology 35 (7) (2016)
S Kaufmann, Jens Bedke, S Gatidis, J Hennenlotter, U Kramer, M Notohamiprodjo, K Nikolaou, A Stenzl, S Kruck
Prostate cancer gene 3 (PCA3) is of additional predictive value in patients with PI-RADS grade III (intermediate) lesions in the MR-guided re-biopsy setting for prostate cancer. World journal of urology 34 (4) (2015)